Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_781234f3bbb66c6fda75dc8db9f2a283 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-7061 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-556 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-703 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-70 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-55 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-551 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-675 |
filingDate |
2001-07-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0ca9dfb9d7da48143c27273cd9992d68 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a7e3ba46fff1b68068cf651526ad2073 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8dffdb3ee643ae4dc8a2b0e96569b31f http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4906ebde002256f3f8b2e81b5caff715 |
publicationDate |
2003-04-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
EP-1299091-A2 |
titleOfInvention |
Matrix controlled transdermal system for stabile derivatives of ace inhibitors |
abstract |
In a transdermal therapeutic system (TTS) comprising an impermeable backing layer, one or more matrix layers and a removable backing layer, the matrix layers contain active agent(s) (A) consisting of a dicarboxylic acid angiotensin converting enzyme (ACE) inhibitor which has been derivatized to give a diester, a di-salt with base(s) or a mono-salt with acid(s). In a transdermal therapeutic system (TTS) comprising an impermeable backing layer, one or more matrix layers (where at least one of the layers is self-adhesive or a separate adhesive layer is provided) and a removable backing layer, the matrix layers contain active agent(s) (A) consisting of a dicarboxylic acid angiotensin converting enzyme (ACE) inhibitor which has been derivatized to give a diester, a di-salt with base(s) or a mono-salt with acid(s). |
priorityDate |
2000-07-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |